UC - ULCERATIVE COLITIS
Clinical trials for UC - ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new UC - ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for UC - ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could replace steroids for severe colitis Flare-Ups
Disease control Not yet recruitingThis study tests whether the oral medication upadacitinib can safely treat adults hospitalized with a severe flare of ulcerative colitis. The goal is to see if it can reduce the need for emergency surgery or rescue treatments by day 14, and whether it can be used without steroids…
Matched conditions: UC - ULCERATIVE COLITIS
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New ulcerative colitis drug candidate begins first human safety tests
Knowledge-focused Not yet recruitingThis early-stage study is testing a new drug called LYNC-101 in 50 healthy adults to see if it is safe and how the body handles it. The study has two parts: one where volunteers get a single dose, and another where they get three doses over several weeks. This research is needed …
Matched conditions: UC - ULCERATIVE COLITIS
Phase: PHASE1 • Sponsor: LyncBio Therapeutics Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 04:13 UTC